Brief: Kontafarma China Sees Consol Net Loss Loss In Range Of HK$43.2 Mln To HK$64.8 Mln For FY
06/03/2023 10:28
March 6 (Reuters) - Kontafarma China Holdings Ltd
1312.HK :
* SEES CONSOLIDATED NET LOSS LOSS IN REGION OF
APPROXIMATELY
HK$43.2 MILLION TO HK$64.8 MILLION FOR FY 2022
* EXPECTED RESULT DUE TO INCREASE IN EXPECTED CREDIT LOSSES
ON
RECEIVABLES IN FITNESS BUSINESS OF GROUP FOR FY 2022, AMONG
OTHERS
Source text for Eikon: ID:
Further company coverage: 1312.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr